The antiplatelet activity of magnolol is mediated by PPAR-β/γ
Authors:
- Tz-Chong ChouTCTz-Chong Chou
- 1 September 2012
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 84 (6) , 793-803
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of Taiwan, Republic of China (NSC97-2320-B-016-008-MY3)
This publication has 29 references indexed in Scilit:
- Inhibitory Effect of α-Lipoic Acid on Platelet Aggregation Is Mediated by PPARsJournal of Agricultural and Food Chemistry, 2011
- PPARs and the Cardiovascular SystemAntioxidants & Redox Signaling, 2009
- Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosisThrombosis and Haemostasis, 2009
- A pilot study showing an association between platelet hyperactivity and the severity of peripheral arterial diseasePlatelets, 2007
- Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβThe FASEB Journal, 2005
- Retinoid X Receptor Heterodimers in the Metabolic SyndromeNew England Journal of Medicine, 2005
- The potential role of platelet microparticles in atherosclerosisThrombosis and Haemostasis, 2005
- Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammationThe Journal of Steroid Biochemistry and Molecular Biology, 2003
- Platelets and cardiovascular diseaseEuropean Journal of Cardiovascular Nursing, 2002